XML 31 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2012
Share Based Compensation [Abstract]  
Summary of outstanding stock option grants and transactions
A summary of outstanding stock option grants and transactions follows:

   
Nine-months ended September 30, 2012
 
      
Weighted-
Average
Remaining
  
 
Aggregated
 
   
Number of Shares
  
Average Exercise
Price
  
Contractual Term
(years)
  
Intrinsic
Value (in thousands)
 
              
Outstanding at January 1, 2012
  180,862  $7.98       
Granted
  113,400   2.70       
Exercised
  (1,401)  1.92       
Forfeited
  (11,666)  1.92       
Expired
  (5,495)  90.66       
Outstanding at September 30, 2012
  275,700  $4.45   8.67  $100 
Vested and expected to vest at September 30, 2012
  253,972  $4.62   8.60  $94 
Exercisable at September 30, 2012
  77,881  $9.73   7.04  $32 
Summary of non-vested restricted stock and stock units and transactions
A summary of non-vested restricted stock and stock units and transactions follows:

   
2012
 
 
 
 
 Number of Shares
  
Weighted
Average
Grant Date
Fair Value
 
        
Outstanding at January 1, 2012
  165,045  $17.90 
Granted
  221,147   2.78 
Vested
  (4,496)  166.90 
Forfeited
  (522)  93.14 
Outstanding at September 30, 2012
  381,174  $7.27 
Weighted-average assumptions used in the Black-Scholes option pricing model for grants of stock options
A summary of the weighted-average assumptions used in the Black-Scholes option pricing model for grants of stock options during 2012 follows:

Expected dividend yield
  0.74%
Risk-free interest rate
  0.88 
Expected life (in years)
  6.00 
Expected volatility
  100.00%
Per share weighted-average fair value
 $2.02 
Information regarding options exercised
The following summarizes certain information regarding options exercised during the three- and nine-month periods ended September 30:

   
Three months ended
  
Nine months ended
 
   
September 30,
  
September 30,
 
   
2012
  
2011
  
2012
  
2011
 
   
(In thousands)
 
Intrinsic value
 $1  $-  $1  $- 
Cash proceeds received
 $3  $-  $3  $- 
Tax benefit realized
 $-  $-  $-  $-